Lutz B. Giebel
Président chez Orange Grove Bio LLC
Provenance du réseau au premier degré de Lutz B. Giebel
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Avera Pharmaceuticals, Inc.
 Avera Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Avera Pharmaceuticals, Inc. develops drugs and therapies. The company's pharmaceutical compounds are used to identify opportunities for therapeutic advances in the treatment of neurological and psychiatric disorders. Avera Pharmaceuticals was founded in 2002 and is headquartered in San Diego, CA.
11
| Extinct | Medical/Nursing Services | 11 |
Sapphire Therapeutics, Inc.
 Sapphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sapphire Therapeutics, Inc. develops biopharmaceutical products. It develops compounds for the treatment of oncologic and metabolic diseases. The firm products include anamorelin for the treatment of anorexia and cachexia. The company was founded in 2000 and is headquartered in Bridgewater, NJ.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Spybiotech Ltd.
 Spybiotech Ltd. BiotechnologyHealth Technology Spybiotech Ltd. develops molecular superglue which it believes can be used to create vaccines. The company was founded by Sumit Biswas and is headquartered in Oxford, the United Kingdom.
4
| Holding Company | Biotechnology | 4 |
IpiNovyx Bio, Inc.
 IpiNovyx Bio, Inc. Medical/Nursing ServicesHealth Services IpiNovyx Bio, Inc. is a drug development and platform technology company that focuses on developing novel therapeutics to treat autoimmune and inflammatory diseases through selective inhibition of the immunoproteasome. The company is based in West Nyack, NY. The company's platform technology enables highly selective, reversible, and non-toxic inhibition of various immune cell types, with applications across a range of indications with underlying immunopathology. Orange Grove Bio (OGB) is an emerging, preclinical, capital allocation, and asset development biotech company that partners with universities and entrepreneurs to develop innovative treatments for important diseases, particularly cancer and immune disorders. The company was founded by Jim Graham, and the CEO is Marc Appel.
3
| Holding Company | Medical/Nursing Services | 3 |
Orange Grove Bio LLC
 Orange Grove Bio LLC Financial ConglomeratesFinance Orange Grove Bio LLC is a preclinical biotech company that partners with universities and entrepreneurs to develop innovative treatments for important diseases, particularly cancer and immune disorders. The company is based in Cincinnati, OH. The company fosters strong relationships with entrepreneurs and technology transfer offices outside of the traditional medical technology hubs. Orange Grove Bio's team possesses more than one hundred years of drug development and company creation experience, allowing it to build and finance innovative programs from the research and development stage to clinical trials. The company was founded by Marc Appel. Marc Appel has been the CEO since incorporation.
3
| Holding Company | Financial Conglomerates | 3 |
Alba Therapeutics Corp.
 Alba Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical Company focused on the discovery, development and commercialization of pharmaceutical products to treat autoimmune and inflammatory diseases and is based in Baltimore, Maryland. Genetics, environment, aberrant immune response, and barrier dysfunction are all required for autoimmunity. Alba's technology platform is based on modifying disease state epithelial permeability using compounds which impact the regulation of tight junctions in cell barriers throughout the body with potential applications in celiac disease, Crohn's disease, asthma/COPD and acute lung injury. As a development stage company Alba maximizes value creation by leveraging its human capital, partnerships and technology. Since the Company's formation in 2004, the company has entered human clinical trials with its lead product, received Fast Track designation from the FDA (in Celiac Disease), successfully completed three Phase I clinical trials and completed its first Phase II study. Along with $30m raised in its Series A financing, equity and non-equity capital, such as SBIR and ATP grants and venture debt, are being used to develop products, enhance its powerful IP position and build the Company's infrastructure and core competencies
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Lutz B. Giebel via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer | |
| PASSAGE BIO, INC. | Biotechnology | Director/Board Member Director/Board Member Founder | |
| Georgetown University | College/University | Director/Board Member Doctorate Degree Undergraduate Degree | |
| ARMO BIOSCIENCES INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| Stanford University | College/University | Masters Business Admin Undergraduate Degree | |
| MD Edge, Inc. | Corporate Officer/Principal Director of Finance/CFO | ||
Windamere Venture Partners LLC
 Windamere Venture Partners LLC Investment ManagersFinance Windamere Venture Partners LLC (Windamere Venture Partners) is an independent venture capital firm founded in 1999 by Scott L. Glenn. The firm is headquartered in San Diego. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
| The Johns Hopkins University | College/University | Doctorate Degree Doctorate Degree | |
| IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
Recida Therapeutics, Inc.
 Recida Therapeutics, Inc. BiotechnologyHealth Technology Recida Therapeutics, Inc. engages in the development of novel therapeutics. The company was founded by Yigong Ge, Aditya Kohli, and David A. Socks in 2016 and is headquartered in Menlo Park, CA. | Biotechnology | Director/Board Member Founder | |
Scout Bio, Inc.
 Scout Bio, Inc. Pharmaceuticals: MajorHealth Technology Scout Bio, Inc. operates as a biotechnology company that focuses on the innovation of pet medicine by delivering a pipeline of one-time therapeutics for major chronic pet health conditions. It also specializes in gene therapy, veterinary product development and biotechnology investment. The company was founded by James M. Wilson in 2016 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| ARCUTIS BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Founder | |
PathoGenesis Corp
 PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Biotechnology | Sales & Marketing General Counsel | |
| HISTOGEN INC. | Biotechnology | Chairman Chief Executive Officer | |
| HILLEVAX, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
Asalyxa Bio, Inc.
 Asalyxa Bio, Inc. Pharmaceuticals: MajorHealth Technology Asalyxa Bio, Inc. is a drug development and platform technology company that focuses on developing novel therapeutics to treat major unmet medical needs caused by the dysregulation of immune signaling. The company is based in Southfield, MI. The company's platform technology enables the delivery of existing and novel drugs directly into over-reactive immune cells, with applications across a wide array of disease areas and conditions. The company was founded by Marc Appel, who has been the CEO since incorporation. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
| PAREXEL INTERNATIONAL CORPORATION | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Undergraduate Degree Doctorate Degree | |
MBX Biosciences, Inc.
 MBX Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology MBX Biosciences, Inc. operates as a preclinical-stage biotech company. It creates therapies to treat rare endocrine diseases. The company was founded by Peter Kent Hawryluk and Timothy Knickerbocker and is headquartered in Carmel, IN. | Electronic Equipment/Instruments | Director/Board Member Director/Board Member | |
| COLLEGIUM PHARMACEUTICAL, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Private Equity Investor | |
PreCision Dermatology, Inc.
 PreCision Dermatology, Inc. Pharmaceuticals: MajorHealth Technology PreCision Dermatology, Inc. developed skincare therapies. It offered pharmaceutical products for skin barrier restoration, dermatoses, rosacea, acne, seborrheic dermatitis, and scaling associated with hyperkeratotic skin. The company was founded by Jeffrey M. Nugent in 2010 and was headquartered in Cumberland, RI. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Masters Business Admin Masters Business Admin | |
HighCape Partners Management LLC
 HighCape Partners Management LLC Investment ManagersFinance HighCape Partners Management LLC (HighCape Partners) is a private equity firm founded in 2013 by Kevin Rakin and Matt Zuga. The firm headquartered in Westport, Connecticut.. | Investment Managers | Founder | |
AgriMetis LLC
 AgriMetis LLC BiotechnologyHealth Technology AgriMetis LLC operates a biotech company, which engages in the development of crop protection agents. It also offers natural products derived compounds to protect crops from weeds, fungal diseases, and insect pests. Its AgriMetis technology platform employs multidisciplinary and integrated scientific approach that allows access to areas of chemical space and production routes that are inaccessible to others. The company was founded by Philip Goelet, Simon Aspland and Brian Green in March 2014 and is headquartered in Lutherville, MD. | Biotechnology | Director/Board Member | |
NMGF Management LLC
 NMGF Management LLC Investment ManagersFinance NMGF Management LLC (New Markets Venture Partners) is a venture capital firm founded in 2002 by Mark Anthony Grovic and Robb Tyler Doub. The firm is headquartered in Fulton, Maryland. | Investment Managers | Corporate Officer/Principal | |
Syngenta Ventures
 Syngenta Ventures Investment ManagersFinance Syngenta Ventures is a venture capital firm in Switzerland. The firm was founded in 2009. The firm is headquartered in Switzerland. | Investment Managers | Director/Board Member | |
| Stony Brook University | College/University | Corporate Officer/Principal | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Kenan-Flagler Business School | College/University | Masters Business Admin | |
CNS Therapeutics, Inc.
 CNS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology CNS Therapeutics, Inc. develops and manufactures drug delivery products. The company was founded in 2007 and is headquartered in St. Paul, MN. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of San Diego | College/University | Undergraduate Degree | |
Deloitte & Touche
 Deloitte & Touche Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche provides audit, enterprise risk management, and financial advisory services. The company delivers services in four professional areas: audit, tax, consulting, and financial advisory services. It provides its clients with global services such as entering foreign markets, raising funds, and investing in Mainland China. The company was founded in June, 2003 and is headquartered in Taipei, Taiwan. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Legg Mason & Co. LLC (New York) | Corporate Officer/Principal | ||
General Atomics, Inc.
 General Atomics, Inc. Electrical ProductsProducer Manufacturing General Atomics develops and manufactures high-technology products for commercial, and government applications. It offers nuclear fuel cycle, electromagnetic systems, remotely operated surveillance aircraft, airborne sensors, and high-power lasers. The company was founded in 1955 and is headquartered in San Diego, CA. | Electrical Products | Corporate Officer/Principal |
Statistiques
Internationale
| Etats-Unis | 48 |
| Suisse | 2 |
| Taïwan | 2 |
| Royaume-Uni | 2 |
Sectorielle
| Health Technology | 25 |
| Consumer Services | 10 |
| Finance | 7 |
| Commercial Services | 6 |
| Health Services | 2 |
Opérationnelle
| Director/Board Member | 233 |
| Corporate Officer/Principal | 85 |
| Independent Dir/Board Member | 59 |
| Founder | 35 |
| Chairman | 29 |
Relations les plus connectées
| Insiders | |
|---|---|
| Carl Gordon | 59 |
| Daniel Janney | 47 |
| Patrick Heron | 42 |
| Matthew Zuga | 32 |
| Dan Kisner | 29 |
| Bruce Peacock | 28 |
| Patrick J. Fortune | 24 |
| David Socks | 24 |
| Mark Leuchtenberger | 21 |
| Joao Siffert | 14 |
| Bernard King | 13 |
| Susan Knudson | 13 |
| Jim Graham | 11 |
| Jeffrey F. McKelvy | 11 |
| Eddie J. Gray | 10 |
- Bourse
- Insiders
- Lutz B. Giebel
- Connexions Sociétés
